explore -WSS

explore

author：explore 2025-10-01 15:31:05 - browse：753

CHICAGO — A next-generation CAR-T therapy was able to substantially shrink tumors in patients with liver cancer in early clinical data presented Monday at the American Society of Clinical Oncology annual meeting. The study, though preliminary and small with only 24 patients, represents a triad of firsts for one of the trial’s sponsors.

“It’s the first CAR therapy working in liver cancer. First validation of targeting GPC3 as a target. It’s the first validation of our armoring strategy. And it’s the first of many of our visions of CAR therapy in general,” Matt Hellmann, a medical oncologist and early development oncology lead at AstraZeneca, said in an interview.

This abstract, presented by cancer researcher Qi Zhang of Zhejiang University School of Medicine, is yet another significant showing by AstraZeneca at this ASCO. The company had two plenary presentations on its blockbuster lung cancer drug Tagrisso and immunotherapy drug Imfinzi — as well as new results on Enhertu, which AstraZeneca developed with Daiichi Sankyo.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： A public scorecard can help hold safety

leisure time

WSS

AI can’t replace a physician’s gut feeling

Maui's cultural, historic landmarks damaged in the devastating wildfires

Sanders adds drug shortage policies to pandemic preparedness bill

Google and Epic fight stronger regulation of AI in health care

How dance can help nurses traumatized by Covid

AI can’t replace a physician’s gut feeling

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Walensky prepares to leave CDC — and Congress — behind

In early work, researchers turn to CRISPR to treat Alzheimer's

Trump demands the U.S. pay no more for drugs than other countries … again

Emergent cuts jobs, executive role in business shake

At least 13 dead in Texas as scorching temps continue

Wegovy trial has doctors encouraged over new possibilities

After affirmative action ruling, medical educators look to 'holistic review'

In early work, researchers turn to CRISPR to treat Alzheimer's

Psychedelics group wrestles with new pharma identity

American woman, child freed after being kidnapped in Haiti last month

leisure time

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

For Cytokinetics, FDA rejection of heart drug would help, not hinder

Key House panel plots a new health care package

Police still searching for prisoner who escaped from NYC hospital

Anavex keeps shifting the goalposts in its clinical trials

Google and Epic fight stronger regulation of AI in health care

hotspot

entertainment

leisure time

entertainment